Question 1

What is ResMed's P/S ratio?

Accepted Answer

ResMed (RMD) P/S ratio is 5.2× as of June 5, 2026. The ratio is calculated by dividing market capitalisation by trailing twelve-month revenue, using USD-normalised financials (IAS 21 exchange-rate translation for non-USD reporters).

Question 2

How is the P/S ratio calculated?

Accepted Answer

P/S = Market Capitalisation ÷ Trailing Twelve-Month (TTM) Revenue, or equivalently Share Price ÷ TTM Revenue Per Share. All inputs are sourced from audited GAAP/IFRS filings and translated to USD using period-end exchange rates so the multiple is comparable across companies and currencies.

Question 3

What is the P/S ratio?

Accepted Answer

The price-to-sales (P/S) ratio compares a company's market capitalisation to its trailing twelve-month (TTM) revenue. It is calculated as market cap ÷ TTM revenue (equivalent to share price ÷ TTM revenue per share). Because the denominator (revenue) cannot be negative, P/S is widely used to value unprofitable or pre-profit companies and to make cross-sector comparisons.

Question 4

What is a good P/S ratio for ResMed?

Accepted Answer

A "good" P/S depends heavily on profit margin and growth: software and other high-margin businesses often command 5–15× sales, while low-margin retailers and commodity producers typically trade below 1×. Compare against sector peers rather than absolute thresholds. For ResMed specifically, the relevant sector benchmark is the current sector median of 3.5×.

Question 5

Is ResMed's P/S ratio high or low?

Accepted Answer

ResMed's P/S ratio of 5.2× is below its own 5-year average of 7.8× and above the sector median of 3.5×. That places the current reading at the 5th percentile of its 10-year history. A higher multiple usually reflects stronger expected growth, lower perceived risk, or higher returns on capital; a lower multiple reflects the opposite.

Question 6

What is ResMed's historical P/S ratio range?

Accepted Answer

In the available daily series, ResMed (RMD) P/S ratio has ranged from a low of 2.9× in 2011 to a high of 13.6× in 2021. The 5-year average is 7.8× and the 5-year median is 7.5×.

Question 7

What was ResMed's P/S ratio in 2025?

Accepted Answer

ResMed (RMD) P/S ratio at the end of 2025 was 7.3×. Annual values reflect the multiple on the last trading day of each calendar year, using the trailing twelve-month revenue figure available at that date.

Question 8

Why does ResMed's P/S ratio change over time?

Accepted Answer

Valuation multiples move with two inputs: the numerator (market capitalisation, which tracks the share price) and the denominator (revenue). Share-price changes — driven by interest rates, earnings expectations, risk appetite, and broader market sentiment — typically dominate short-term moves, while changes in the underlying fundamental drive the longer-term trend. As a result, the ratio can rise during stock-price rallies even if the business itself has not become more valuable, and fall during sell-offs even when fundamentals are improving.


2025	$37.79B	$5.15B	7.3×	+1.5×	Jun 30, 2025
2024	$27.46B	$4.69B	5.9×	-1.7×	Jun 30, 2024
2023	$32.12B	$4.22B	7.6×	-1.0×	Jun 30, 2023
2022	$30.68B	$3.58B	8.6×	-2.7×	Jun 30, 2022
2021	$35.89B	$3.20B	11.2×	+1.8×	Jun 30, 2021
2020	$27.80B	$2.96B	9.4×	+2.6×	Jun 30, 2020
2019	$17.75B	$2.61B	6.8×	+0.5×	Jun 30, 2019
2018	$14.79B	$2.34B	6.3×	+1.0×	Jun 30, 2018
2017	$11.06B	$2.07B	5.4×	+0.5×	Jun 30, 2017
2016	$8.89B	$1.84B	4.8×	+0.1×	Jun 30, 2016
2015	$7.94B	$1.68B	4.7×	+0.2×	Jun 30, 2015
2014	$7.12B	$1.55B	4.6×	+0.4×	Jun 30, 2014
2013	$6.38B	$1.51B	4.2×	+1.0×	Jun 30, 2013
2012	$4.45B	$1.37B	3.3×	-0.5×	Jun 30, 2012
2011	$4.72B	$1.24B	3.8×	-0.4×	Jun 30, 2011
2010	$4.61B	$1.09B	4.2×	+0.9×	Jun 30, 2010
2009	$3.07B	$920.74M	3.3×	+0.1×	Jun 30, 2009
2008	$2.70B	$835.40M	3.2×	-1.2×	Jun 30, 2008
2007	$3.20B	$716.33M	4.5×	-1.4×	Jun 30, 2007
2006	$3.55B	$607.00M	5.8×	+0.4×	Jun 30, 2006
2005	$2.30B	$425.50M	5.4×	+0.3×	Jun 30, 2005
2004	$1.72B	$339.34M	5.1×	+0.3×	Jun 30, 2004
2003	$1.30B	$273.57M	4.8×	+0.3×	Jun 30, 2003
2002	$910.92M	$204.08M	4.5×	—	Jun 30, 2002


Zimmer Biomet Holdings (ZBH)	2.1×
AptarGroup (ATR)	2.1×
Becton, Dickinson and (BDX)	2.1×
Charles River (CRL)	1.9×
Quest Diagnostics (DGX)	1.9×
IQVIA (IQV)	1.7×
GE HealthCare (GEHC)	1.6×
Labcorp Holdings (LH)	1.6×
HCA Healthcare (HCA)	1.4×
Solventum (SOLV)	1.4×
Viatris (VTRS)	1.1×
Baxter International (BAX)	0.8×
DaVita (DVA)	0.7×
Henry Schein (HSIC)	0.6×
Universal Health Services (UHS)	0.6×
UnitedHealth Group (UNH)	0.5×
Elevance Health (ELV)	0.3×
McKesson (MCK)	0.3×
Cigna (CI)	0.3×
CVS Health (CVS)	0.2×
Cardinal Health (CAH)	0.2×
Cencora (COR)	0.2×
Humana (HUM)	0.2×
Molina Healthcare (MOH)	0.2×
Centene (CNC)	0.1×

P/S Ratio for ResMed (RMD)

P/S Ratio daily chart for ResMed (RMD)

Historical P/S Ratio for ResMed (RMD) from 2002 to 2025

About P/S Ratio at ResMed (RMD)

ResMed P/S Ratio by Year

ResMed P/S Ratio 2025: 7.3×

ResMed P/S Ratio 2024: 5.9×

ResMed P/S Ratio 2023: 7.6×

ResMed P/S Ratio 2022: 8.6×

ResMed P/S Ratio 2021: 11.2×

Sector peers by P/S Ratio — chart

Sector peers by P/S Ratio — table

Frequently asked questions

ResMed (RMD) Key Financials

P/S Ratio daily chart for ResMed (RMD)

Historical P/S Ratio for ResMed (RMD) from 2002 to 2025

About P/S Ratio at ResMed (RMD)

ResMed P/S Ratio by Year

ResMed P/S Ratio 2025: 7.3×

ResMed P/S Ratio 2024: 5.9×

ResMed P/S Ratio 2023: 7.6×

ResMed P/S Ratio 2022: 8.6×

ResMed P/S Ratio 2021: 11.2×

Sector peers by P/S Ratio — chart

Sector peers by P/S Ratio — table

Frequently asked questions

+What is ResMed's P/S ratio?

+How is the P/S ratio calculated?

+What is the P/S ratio?

+What is a good P/S ratio for ResMed?

+Is ResMed's P/S ratio high or low?

+What is ResMed's historical P/S ratio range?

+What was ResMed's P/S ratio in 2025?

+Why does ResMed's P/S ratio change over time?

ResMed (RMD) Key Financials